|
OMIM |
Link |
Information gain |
01 |
|
thrombocytopenia, autosomal recessive
|
[NCBI]
|
0.000975924
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.000876099
|
|
|
SCAR2
|
[NCBI]
|
0.00081137
|
|
|
AMCN
|
[NCBI]
|
0.000621449
|
|
|
IDDM
|
[NCBI]
|
0.000586259
|
|
|
anencephaly
|
[NCBI]
|
0.000585429
|
|
|
coffin-siris syndrome
|
[NCBI]
|
0.000555296
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.00046006
|
|
|
SPS
|
[NCBI]
|
0.000404095
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
0.000283174
|
|
|
mullerian aplasia
|
[NCBI]
|
0.000243906
|
|
|
isotretinoin embryopathy-like syndrome
|
[NCBI]
|
0.000226633
|
|
|
heart block, congenital
|
[NCBI]
|
0.000170519
|
|
|
SRS
|
[NCBI]
|
0.000169263
|
|
|
EFE
|
[NCBI]
|
0.000144606
|
|
|
renal tubulopathy, diabetes mellitus, and cerebellar ataxia due to duplication of mitochondrial dna
|
[NCBI]
|
0.000140914
|
|
|
MG
|
[NCBI]
|
0.000126132
|
|
|
CPI
|
[NCBI]
|
0.000117317
|
|
|
hypercalcemia, idiopathic, of infancy
|
[NCBI]
|
0.000113158
|
|
|
AFP
|
[NCBI]
|
0.000100671
|
|
|
carbimazole sensitivity
|
[NCBI]
|
9.5902e-05
|
|
|
oeis complex
|
[NCBI]
|
8.68408e-05
|
|
|
valproate embryopathy, susceptibility to
|
[NCBI]
|
8.35036e-05
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
8.35036e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
8.35036e-05
|
|
|
CRH
|
[NCBI]
|
7.31307e-05
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
7.04932e-05
|
|
|
omenn syndrome
|
[NCBI]
|
6.75534e-05
|
|
|
ICP
|
[NCBI]
|
6.49989e-05
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
6.17037e-05
|
|
|
HPA-2
|
[NCBI]
|
6.1318e-05
|
|
|
RTD
|
[NCBI]
|
5.97823e-05
|
|
|
SERPINA6
|
[NCBI]
|
5.78642e-05
|
|
|
PRL
|
[NCBI]
|
5.72739e-05
|
|
|
RCDP1
|
[NCBI]
|
5.56803e-05
|
|
|
FCGRT
|
[NCBI]
|
5.45928e-05
|
|
|
graves disease
|
[NCBI]
|
5.35841e-05
|
|
|
RBS
|
[NCBI]
|
5.29337e-05
|
|
|
CF
|
[NCBI]
|
5.06783e-05
|
|
|
FIH
|
[NCBI]
|
4.99798e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
4.93214e-05
|
|
|
HSAN3
|
[NCBI]
|
4.69562e-05
|
|
|
RA
|
[NCBI]
|
4.47801e-05
|
|
|
phenylketonuria
|
[NCBI]
|
4.41491e-05
|
|
|
CSH1
|
[NCBI]
|
4.40649e-05
|
|
|
SLE
|
[NCBI]
|
4.39323e-05
|
|
|
AMC
|
[NCBI]
|
4.35648e-05
|
|
|
CGB
|
[NCBI]
|
4.33904e-05
|
|
|
HLA-G
|
[NCBI]
|
4.15737e-05
|
|
|
trophoblast-lymphocyte crossreactive antigen
|
[NCBI]
|
4.06481e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
3.91208e-05
|
|
|
CYP1A1
|
[NCBI]
|
3.88591e-05
|
|
|
ND
|
[NCBI]
|
3.88203e-05
|
|
|
SMA1
|
[NCBI]
|
3.58126e-05
|
|
|
EPHX1
|
[NCBI]
|
3.52531e-05
|
|
|
CHAT
|
[NCBI]
|
3.30762e-05
|
|
|
ADHD
|
[NCBI]
|
3.06391e-05
|
|
|
CART1
|
[NCBI]
|
2.93003e-05
|
|
|
AVP
|
[NCBI]
|
2.8342e-05
|
|
|
LPL
|
[NCBI]
|
2.80566e-05
|
|
|
KSS
|
[NCBI]
|
2.75927e-05
|
|
|
MYOM2
|
[NCBI]
|
2.72851e-05
|
|
|
PTH
|
[NCBI]
|
2.72627e-05
|
|
|
HSCR1
|
[NCBI]
|
2.58393e-05
|
|
|
TECTB
|
[NCBI]
|
2.57882e-05
|
|
|
TNFSF6
|
[NCBI]
|
2.32112e-05
|
|
|
RBP1
|
[NCBI]
|
2.19367e-05
|
|
|
WBS
|
[NCBI]
|
2.17336e-05
|
|
|
PDCD1LG1
|
[NCBI]
|
2.07757e-05
|
|
|
RTN1
|
[NCBI]
|
2.07757e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
2.01334e-05
|
|
|
SFRP4
|
[NCBI]
|
1.97506e-05
|
|
|
ID3
|
[NCBI]
|
1.97506e-05
|
|
|
GHRH
|
[NCBI]
|
1.95836e-05
|
|
|
SLC27A1
|
[NCBI]
|
1.888e-05
|
|
|
ID1
|
[NCBI]
|
1.84895e-05
|
|
|
LTF
|
[NCBI]
|
1.74557e-05
|
|
|
ID2
|
[NCBI]
|
1.71489e-05
|
|
|
MME
|
[NCBI]
|
1.68577e-05
|
|
|
LAMB3
|
[NCBI]
|
1.60642e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.60555e-05
|
|
|
ACHE
|
[NCBI]
|
1.53637e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.49792e-05
|
|
|
TNF
|
[NCBI]
|
1.43306e-05
|
|
|
VEGF
|
[NCBI]
|
1.41623e-05
|
|
|
RAG1
|
[NCBI]
|
1.32231e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.29346e-05
|
|
|
TG
|
[NCBI]
|
1.28789e-05
|
|
|
SMN2
|
[NCBI]
|
1.27959e-05
|
|
|
EGFR
|
[NCBI]
|
1.24738e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
1.23632e-05
|
|
|
DAZ
|
[NCBI]
|
1.21511e-05
|
|
|
DMPK
|
[NCBI]
|
1.19134e-05
|
|
|
PZP
|
[NCBI]
|
1.19134e-05
|
|
|
CFB
|
[NCBI]
|
1.13616e-05
|
|
|
IGF2
|
[NCBI]
|
1.07677e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.01502e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
9.90751e-06
|
|
|
PCNA
|
[NCBI]
|
9.18399e-06
|
|
|
MTTL1
|
[NCBI]
|
9.10385e-06
|
|
|
HLA-A
|
[NCBI]
|
8.41233e-06
|
|
|
homocystinuria
|
[NCBI]
|
8.12784e-06
|
|
|
PAEP
|
[NCBI]
|
7.85935e-06
|
|
|
PRLR
|
[NCBI]
|
7.80743e-06
|
|
|
VIM
|
[NCBI]
|
7.65503e-06
|
|
|
PC
|
[NCBI]
|
7.31769e-06
|
|
|
UCN
|
[NCBI]
|
6.91751e-06
|
|
|
CCND1
|
[NCBI]
|
6.66919e-06
|
|
|
CCK
|
[NCBI]
|
6.39175e-06
|
|
|
TBP
|
[NCBI]
|
6.06843e-06
|
|
|
CEACAM5
|
[NCBI]
|
5.80803e-06
|
|
|
ABCB1
|
[NCBI]
|
5.76422e-06
|
|
|
NPY
|
[NCBI]
|
5.66817e-06
|
|
|
IL6
|
[NCBI]
|
5.54209e-06
|
|
|
CASR
|
[NCBI]
|
5.45046e-06
|
|
|
ABCG2
|
[NCBI]
|
5.02135e-06
|
|
|
OXT
|
[NCBI]
|
4.61046e-06
|
|
|
PTHLH
|
[NCBI]
|
4.17487e-06
|
|
|
FA
|
[NCBI]
|
3.90609e-06
|
|
|
PLG
|
[NCBI]
|
3.74904e-06
|
|
|
TTR
|
[NCBI]
|
3.60028e-06
|
|
|
POMC
|
[NCBI]
|
3.52674e-06
|
|
|
TH
|
[NCBI]
|
3.49672e-06
|
|
|
HGF
|
[NCBI]
|
3.49019e-06
|
|
|
VIP
|
[NCBI]
|
3.40675e-06
|
|
|
TF
|
[NCBI]
|
3.3398e-06
|
|
|
PDCD8
|
[NCBI]
|
3.06486e-06
|
|
|
GHR
|
[NCBI]
|
3.03434e-06
|
|
|
PNMT
|
[NCBI]
|
2.84342e-06
|
|
|
AHR
|
[NCBI]
|
2.41507e-06
|
|
|
F3
|
[NCBI]
|
2.41315e-06
|
|
|
CP
|
[NCBI]
|
2.38671e-06
|
|
|
LCAT
|
[NCBI]
|
2.21329e-06
|
|
|
LDLR
|
[NCBI]
|
2.20216e-06
|
|
|
PPARA
|
[NCBI]
|
2.11634e-06
|
|
|
CAT
|
[NCBI]
|
2.05934e-06
|
|
|
TPO
|
[NCBI]
|
1.96976e-06
|
|
|
GIP
|
[NCBI]
|
1.86201e-06
|
|
|
NPPA
|
[NCBI]
|
1.52946e-06
|
|
|
EGF
|
[NCBI]
|
1.08014e-06
|
|
|
PYY
|
[NCBI]
|
6.50612e-07
|
|
|
VDR
|
[NCBI]
|
5.12207e-07
|
|
|
EPO
|
[NCBI]
|
3.86185e-07
|
|
|
G6PD
|
[NCBI]
|
3.04444e-07
|
|
|
GFAP
|
[NCBI]
|
2.97677e-07
|
|
|
COMT
|
[NCBI]
|
2.52261e-07
|
|
|
MBP
|
[NCBI]
|
1.94025e-07
|
|
|
AR
|
[NCBI]
|
4.65788e-08
|
|
|
GNRH1
|
[NCBI]
|
2.52905e-08
|
|
|
HBB
|
[NCBI]
|
1.29306e-08
|
|
|
BDNF
|
[NCBI]
|
5.70634e-09
|
|
|
NGFB
|
[NCBI]
|
4.43271e-10
|
|